Weight Loss After Anti-Obesity Meds Tied to Lower Gout Risk

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout flares in patients with overweight or obesity.
Medscape Medical News